Measurements of 170H-progesterone in blood spot and saliva are useful to monitor treatment in patients with congenital adrenal hyperplasia.1 The measurement of plasma androstenedione concentrations has also been suggested.2 Androstenedione is a weak adrenal androgen and, unlike 170H-progesterone, single measurements are less affected by wide circadian variations in plasma concentrations. This study reports the use of salivary androstenedione profiles to monitor treatment in congenital adrenal hyperplasia. The results are compared with single random measurements of plasma androstenedione, testosterone, and 170H-progesterone as indices of the degree of control.
Patients and methods
Twenty four patients aged 2 to 22 years with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, provided data for the study. Androstenedione profiles were measured in 17 patients 11 of whom were female over a two year period. Samples of saliva were collected at home at 0800, 1200, 1800, and 2200 hours, on two consecutive weekend days. A profile represents androstenedione concentrations during one day. The dose of glucocorticoid, given either as hydrocortisone in divided doses or as dexamethasone once daily, was adjusted according to clinical indices of control, and single random measurements of plasma 170H-progesterone, testosterone, androstenedione concentrations, and where appropriate, plasma renin activity. Androstenedione profiles in two pubertal male patients were excluded from the analysis because of predominant testicular production at this age. The remaining 11 pubertal female patients and four prepubertal children provided a total of 44 profiles (28 and 16, respectively) for analysis. Data from an additional 11 incomplete profiles were also included in the analysis where appropriate.
The result of each salivary androstenedione profile was compared with the plasma testosterone concentration that had been measured in a morning blood sample collected at a recent clinic. Data from pubertal female patients and prepubertal children were analysed separately according to the normal testosterone values for these ages-that is, 0-32-5 nmol/l and <0*5 nmol/l, respectively. fig 6) . Fig 7 and table 3 show how salivary androstenedione profiles can distinguish adequate from poor control We have shown an association between salivary androstenedione and plasma testosterone concentrations. There was a circadian rhythm in androstenedione concentrations in treated patients with congenital adrenal hyperplasia irrespective of age, sex, or stage of puberty. The magnitude of the circadian rhythm was less than for 170H-progesterone' but the accuracy of the salivary androstenedione nomograin for predicting adequacy of control in pubertal girls was still 90%. The nomogram was less discriminant as only two groups (adequate and poor control) could be identified. Only a small number of profiles from prepubertal children were available for analysis. There was a positive correlation between salivary androstenedione and plasma testosterone concentrations at most sampling times. The nomogram (fig 7) provides only an approximate guide to the control of treatment until the values for salivary androstenedione that will distinguish degrees of control are more precisely defined.
Androstenedione is a weak androgen which is secreted by both the adrenal glands and the gonads. Measurement of it in patients with congenital adrenal hyperplasia provides a useful marker of excessive adrenal androgen production, particularly in pubertal male patients. Salivary androstenedione profiles show a circadian rhythm that is closely associated with plasma testosterone concentrations, particularly in pubertal female patients. The profiles may be used alone, or in conjunction with 17(Hprogesterone to monitor androgen production.'
When the profiles of both steroids are used it is possible to achieve a sensitive degree of control and an index of androgen production in those patients who are reluctant to have blood samples taken.
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